Skip to main content
Top
Published in: Endocrine Pathology 1/2017

01-03-2017

Dopamine-Secreting Paraganglioma in the Retroperitoneum

Authors: Yusuke Matsuda, Noriko Kimura, Takanobu Yoshimoto, Yoshihiro Sekiguchi, Junzo Tomoishi, Ichiro Kasahara, Yoshihito Hara, Yoshihiro Ogawa

Published in: Endocrine Pathology | Issue 1/2017

Login to get access

Abstract

Pheochromocytomas and paragangliomas, which exclusively produce dopamine, are very rare. Herein, we report for the first time a Japanese case of an exclusively dopamine-producing paraganglioma accompanied by detailed immunohistochemical analyses. A 70-year-old Japanese woman was referred to our hospital for functional examination of her left retroperitoneal mass. Her adrenal functions were normal, except for excessive dopamine secretion. After the tumorectomy, her dopamine level normalized. The histopathological diagnosis of the tumor was paraganglioma; this was confirmed by positive immunostaining of chromogranin A (CgA), tyrosine hydroxylase (TH), dopamine β-hydroxylase (DBH), and succinate dehydrogenase gene subunit B (SDHB). However, the immunostaining of CgA in the tumor cells showed peculiar dot-like staining located corresponding to Golgi complex in the perinuclear area, rather than the diffuse cytoplasmic staining usually observed in epinephrine- or norepinephrine-producing functional pheochromocytomas and paragangliomas. The immunohistochemical results suggested that the tumor cells had sparse neuroendocrine granules in the cytoplasm, resulting in inhibition of catecholamine synthesis from dopamine to norepinephrine in neurosecretory granules. This may be the mechanism responsible for exclusive dopamine secretion in the present case.
Literature
1.
go back to reference Eisenhofer G, Goldstein DS, Sullivan P, Csako G, Brouwers FM, Lai EW, Adams KT, Pacak K. Biochemical and clinical manifestations of dopamine-producing paragangliomas: utility of plasma methoxytyramine. J Clin Endocrinol Metab 90:2068–2075, 2005.CrossRefPubMed Eisenhofer G, Goldstein DS, Sullivan P, Csako G, Brouwers FM, Lai EW, Adams KT, Pacak K. Biochemical and clinical manifestations of dopamine-producing paragangliomas: utility of plasma methoxytyramine. J Clin Endocrinol Metab 90:2068–2075, 2005.CrossRefPubMed
2.
go back to reference Kimura N, Takayanagi R, Takizawa N, Itagaki E, Katabami T, Kakoi N, Rakugi H, Ikeda Y, Tanabe A, Nigawara T, Ito S, Kimura I, Naruse M; Phaeochromocytoma Study Group in Japan. Pathological grading for predicting metastasis in phaeochromocytoma and paraganglioma. Endocr Relat Cancer 21:405–414, 2014.CrossRefPubMed Kimura N, Takayanagi R, Takizawa N, Itagaki E, Katabami T, Kakoi N, Rakugi H, Ikeda Y, Tanabe A, Nigawara T, Ito S, Kimura I, Naruse M; Phaeochromocytoma Study Group in Japan. Pathological grading for predicting metastasis in phaeochromocytoma and paraganglioma. Endocr Relat Cancer 21:405–414, 2014.CrossRefPubMed
3.
go back to reference Kimura N, Capella C, DeLellis RA, Epstein JI, Gill A, Kawashima A, Koch C, Komminoth P, Lam A KY, Merino MJ, Mete O, Papathomas TG, Sadow P, Thompson LDR, Tischler AS, Williams MD, Young WF. Extra-adrenal paragangliomas. In: Lloyd RV, Kloppel G, Osamura RY, Rosai J, eds. World Health Organization Classification of Tumours. Pathology and Genetics of Tumours of Endocrine Organs. Lyon, IARC, 2017, in press. Kimura N, Capella C, DeLellis RA, Epstein JI, Gill A, Kawashima A, Koch C, Komminoth P, Lam A KY, Merino MJ, Mete O, Papathomas TG, Sadow P, Thompson LDR, Tischler AS, Williams MD, Young WF. Extra-adrenal paragangliomas. In: Lloyd RV, Kloppel G, Osamura RY, Rosai J, eds. World Health Organization Classification of Tumours. Pathology and Genetics of Tumours of Endocrine Organs. Lyon, IARC, 2017, in press.
4.
go back to reference Poirier É, Thauvette D, Hogue JC. Management of exclusively dopamine-secreting abdominal pheochromocytomas. J Am Coll Surg 216:340–346, 2013.CrossRefPubMed Poirier É, Thauvette D, Hogue JC. Management of exclusively dopamine-secreting abdominal pheochromocytomas. J Am Coll Surg 216:340–346, 2013.CrossRefPubMed
5.
go back to reference van Gelder T, Verhoeven GT, de Jong P, Oei HY, Krenning EP, Vuzevski VD, van den Meiracker AH. Dopamine-producing paraganglioma not visualized by iodine-123-MIBG scintigraphy. J Nucl Med 36:620–622, 1995.PubMed van Gelder T, Verhoeven GT, de Jong P, Oei HY, Krenning EP, Vuzevski VD, van den Meiracker AH. Dopamine-producing paraganglioma not visualized by iodine-123-MIBG scintigraphy. J Nucl Med 36:620–622, 1995.PubMed
6.
go back to reference Smith SL, Slappy AL, Fox TP, Scolapio JS. Pheochromocytoma producing vasoactive intestinal peptide. Mayo Clin Proc 77:97–100, 2002.CrossRefPubMed Smith SL, Slappy AL, Fox TP, Scolapio JS. Pheochromocytoma producing vasoactive intestinal peptide. Mayo Clin Proc 77:97–100, 2002.CrossRefPubMed
7.
go back to reference Tam V, Ng KF, Fung LM, Wong YY, Chan MH, Lam CW, Tam S, Lam CW. The importance of the interpretation of urine catecholamines is essential for the diagnosis and management of patient with dopamine-secreting paraganglioma. Ann Clin Biochem 42:73–77, 2005.CrossRefPubMed Tam V, Ng KF, Fung LM, Wong YY, Chan MH, Lam CW, Tam S, Lam CW. The importance of the interpretation of urine catecholamines is essential for the diagnosis and management of patient with dopamine-secreting paraganglioma. Ann Clin Biochem 42:73–77, 2005.CrossRefPubMed
8.
go back to reference Yi JW, Oh EM, Lee KE, Choi JY, Koo do H, Kim KJ, Jung KC, Kim SY, Youn YK. An exclusively dopamine secreting paraganglioma in the retroperitoneum: a first clinical case in Korea. J Korean Surg Soc 82:389–393, 2012.CrossRefPubMedPubMedCentral Yi JW, Oh EM, Lee KE, Choi JY, Koo do H, Kim KJ, Jung KC, Kim SY, Youn YK. An exclusively dopamine secreting paraganglioma in the retroperitoneum: a first clinical case in Korea. J Korean Surg Soc 82:389–393, 2012.CrossRefPubMedPubMedCentral
9.
go back to reference Feldman JM, Blalock JA, Zern RT, Shelburne JD, Gaede JT, Farrell RE, Wells SA Jr Deficiency of dopamine-beta-hydroxylase. A new mechanism for normotensive pheochromocytomas. Am J Clin Pathol 72:175–185, 1979.CrossRefPubMed Feldman JM, Blalock JA, Zern RT, Shelburne JD, Gaede JT, Farrell RE, Wells SA Jr Deficiency of dopamine-beta-hydroxylase. A new mechanism for normotensive pheochromocytomas. Am J Clin Pathol 72:175–185, 1979.CrossRefPubMed
10.
go back to reference Louthan O. Chromogranin a in physiology and oncology. Folia Biol 57:173–181, 2011. Louthan O. Chromogranin a in physiology and oncology. Folia Biol 57:173–181, 2011.
11.
go back to reference Kimura N, Capella C, De Kriiger RR, Thompson LDR, Lam KY, Komminoth P, Tishler AS, Young Jr WF. Extra-adrenal sympathetic paraganglioma: superior and inferior paraaortic. In: DeLellis RA, Lloyd RV, Heitz PU, Eng C, eds. World Health Organization Classification of Tumours. Pathology and Genetics of Tumours of Endocrine Organs. Lyon, IARC, 2004. Kimura N, Capella C, De Kriiger RR, Thompson LDR, Lam KY, Komminoth P, Tishler AS, Young Jr WF. Extra-adrenal sympathetic paraganglioma: superior and inferior paraaortic. In: DeLellis RA, Lloyd RV, Heitz PU, Eng C, eds. World Health Organization Classification of Tumours. Pathology and Genetics of Tumours of Endocrine Organs. Lyon, IARC, 2004.
12.
go back to reference Asa SL. Tumors of the Pituitary Gland. Fascicle 15, 4th Series. The Atlas of Tumor Pathology. Armed Forces Institute of Pathology: Washington DC, 2011. Asa SL. Tumors of the Pituitary Gland. Fascicle 15, 4th Series. The Atlas of Tumor Pathology. Armed Forces Institute of Pathology: Washington DC, 2011.
14.
go back to reference Proye C, Fossati P, Fontaine P, Lefebvre J, Decoulx M, Wemeau JL, Dewailly D, Rwamasirabo E, Cecat P. Dopamine-secreting pheochromocytoma: an unrecognized entity? Classification of pheochromocytomas according to their type of secretion. Surgery 100:1154–1162, 1986.PubMed Proye C, Fossati P, Fontaine P, Lefebvre J, Decoulx M, Wemeau JL, Dewailly D, Rwamasirabo E, Cecat P. Dopamine-secreting pheochromocytoma: an unrecognized entity? Classification of pheochromocytomas according to their type of secretion. Surgery 100:1154–1162, 1986.PubMed
15.
go back to reference van der Harst E, de Herder WW, de Krijger RR, Bruining HA, Bonjer HJ, Lamberts SW, van den Meiracker AH, Stijnen TH, Boomsma F. The value of plasma markers for the clinical behaviour of phaeochromocytomas. Eur J Endocrinol 147:85–94, 2002.CrossRefPubMed van der Harst E, de Herder WW, de Krijger RR, Bruining HA, Bonjer HJ, Lamberts SW, van den Meiracker AH, Stijnen TH, Boomsma F. The value of plasma markers for the clinical behaviour of phaeochromocytomas. Eur J Endocrinol 147:85–94, 2002.CrossRefPubMed
16.
go back to reference Eisenhofer G, Tischler AS, de Krijger RR. Diagnostic tests and biomarkers for pheochromocytoma and extra-adrenal paraganglioma: from routine laboratory methods to disease stratification. Endocr Pathol 23:4–14, 2012.CrossRefPubMed Eisenhofer G, Tischler AS, de Krijger RR. Diagnostic tests and biomarkers for pheochromocytoma and extra-adrenal paraganglioma: from routine laboratory methods to disease stratification. Endocr Pathol 23:4–14, 2012.CrossRefPubMed
17.
go back to reference van Nederveen FH, Gaal J, Favier J, Korpershoek E, Oldenburg RA, de Bruyn EM, Sleddens HF, Derkx P, Rivière J, Dannenberg H, Petri BJ, Komminoth P, Pacak K, Hop WC, Pollard PJ, Mannelli M, Bayley JP, Perren A, Niemann S, Verhofstad AA, de Bruïne AP, Maher ER, Tissier F, Méatchi T, Badoual C, Bertherat J, Amar L, Alataki D, Van Marck E, Ferrau F, François J, de Herder WW, Peeters MP, van Linge A, Lenders JW, Gimenez-Roqueplo AP, de Krijger RR, Dinjens WN. An immunohistochemical procedure to detect patients with paraganglioma and phaeochromocytoma with germline SDHB, SDHC, or SDHD gene mutations: a retrospective and prospective analysis. Lancet Oncol 10:764–771, 2009.CrossRefPubMedPubMedCentral van Nederveen FH, Gaal J, Favier J, Korpershoek E, Oldenburg RA, de Bruyn EM, Sleddens HF, Derkx P, Rivière J, Dannenberg H, Petri BJ, Komminoth P, Pacak K, Hop WC, Pollard PJ, Mannelli M, Bayley JP, Perren A, Niemann S, Verhofstad AA, de Bruïne AP, Maher ER, Tissier F, Méatchi T, Badoual C, Bertherat J, Amar L, Alataki D, Van Marck E, Ferrau F, François J, de Herder WW, Peeters MP, van Linge A, Lenders JW, Gimenez-Roqueplo AP, de Krijger RR, Dinjens WN. An immunohistochemical procedure to detect patients with paraganglioma and phaeochromocytoma with germline SDHB, SDHC, or SDHD gene mutations: a retrospective and prospective analysis. Lancet Oncol 10:764–771, 2009.CrossRefPubMedPubMedCentral
Metadata
Title
Dopamine-Secreting Paraganglioma in the Retroperitoneum
Authors
Yusuke Matsuda
Noriko Kimura
Takanobu Yoshimoto
Yoshihiro Sekiguchi
Junzo Tomoishi
Ichiro Kasahara
Yoshihito Hara
Yoshihiro Ogawa
Publication date
01-03-2017
Publisher
Springer US
Published in
Endocrine Pathology / Issue 1/2017
Print ISSN: 1046-3976
Electronic ISSN: 1559-0097
DOI
https://doi.org/10.1007/s12022-016-9457-0

Other articles of this Issue 1/2017

Endocrine Pathology 1/2017 Go to the issue